Gene · 3587
Papers3,503
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,503
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell sequencing reveals the evolution of immune molecules across multiple vertebrate species. | J Adv Res | 2024 | 36871615 | PubTator, text mining | PubMed |
| Gamma/delta T cells as cellular vehicles for anti-tumor immunity. | Front Immunol | 2023 | 38274800 | PubTator, text mining | PubMed |
| Genetics and clinical phenotypes in common variable immunodeficiency. | Front Genet | 2023 | 38274105 | PubTator, text mining | PubMed |
| The role of miRNAs in T helper cell development, activation, fate decisions and tumor immunity. | Front Immunol | 2023 | 38264670 | PubTator, text mining | PubMed |
| Host-directed therapy against mycobacterium tuberculosis infections with diabetes mellitus. | Front Immunol | 2023 | 38259491 | PubTator, text mining | PubMed |
| Therapeutic significance of tumor microenvironment in cholangiocarcinoma: focus on tumor-infiltrating T lymphocytes. | Explor Target Antitumor Ther | 2023 | 38213535 | PubTator, text mining | PubMed |
| Application of exosomal miRNA mediated macrophage polarization in colorectal cancer: Current progress and challenges. | Oncol Res | 2023 | 38188683 | PubTator, text mining | PubMed |
| Single cell RNA-sequencing profiling to improve the translation between human IBD and in vivo models. | Front Immunol | 2023 | 38179052 | PubTator, text mining | PubMed |
| Antioxidant mechanisms of mesenchymal stem cells and their therapeutic potential in vitiligo. | Front Cell Dev Biol | 2023 | 38178870 | PubTator, text mining | PubMed |
| Single-cell RNA-seq analyses inform necroptosis-associated myeloid lineages influence the immune landscape of pancreas cancer. | Front Immunol | 2023 | 38149248 | PubTator, text mining | PubMed |
| Examining the Safety Profile of Janus Kinase (JAK) Inhibitors in the Management of Immune-Mediated Diseases: A Comprehensive Review. | Life (Basel) | 2023 | 38137845 | PubTator, text mining | PubMed |
| A Narrative Review of Cytokine Networks: Pathophysiological and Therapeutic Implications for Inflammatory Bowel Disease Pathogenesis. | Biomedicines | 2023 | 38137450 | PubTator, text mining | PubMed |
| ncRNAs: an unexplored cellular defense mechanism in leprosy. | Front Genet | 2023 | 38116294 | PubTator, text mining | PubMed |
| Landscape of molecular crosstalk between SARS-CoV-2 infection and cardiovascular diseases: emphasis on mitochondrial dysfunction and immune-inflammation. | J Transl Med | 2023 | 38104081 | PubTator, text mining | PubMed |
| A peptide derived from interleukin-10 exhibits potential anticancer activity and can facilitate cell targeting of gold nanoparticles loaded with anticancer therapeutics. | Commun Chem | 2023 | 38102207 | PubTator, text mining | PubMed |
| A Mendelian randomization study on the causal association of circulating cytokines with colorectal cancer. | PLoS One | 2023 | 38096329 | PubTator, text mining | PubMed |
| The expanding Pandora's toolbox of CD8+T cell: from transcriptional control to metabolic firing. | J Transl Med | 2023 | 38082437 | PubTator, text mining | PubMed |
| Butyrate reduces adherent-invasive E. coli-evoked disruption of epithelial mitochondrial morphology and barrier function: involvement of free fatty acid receptor 3. | Gut Microbes | 2023 | 38078655 | PubTator, text mining | PubMed |
| Blimp-1 and c-Maf regulate Il10 and negatively regulate common and unique proinflammatory gene networks in IL-12 plus IL-27-driven T helper-1 cells. | Wellcome Open Res | 2023 | 38074197 | PubTator, text mining | PubMed |
| Ligand Recognition by the Macrophage Galactose-Type C-Type Lectin: Self or Non-Self?-A Way to Trick the Host's Immune System. | Int J Mol Sci | 2023 | 38069400 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3587/papers?page=11